ANG Lifesciences P/B Ratio
ANG Lifesciences (ANG) P/B ratio is 0.61 (Low), book value per share ₹49.23 vs Healthcare average P/B of -0.93 — Low - Trading below book value, may indicate undervaluation. Compare with ANG DCF valuation to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
ANG P/B Ratio — Valuation Insights & Book Value Analysis
ANG Lifesciences price-to-book ratio interpretation, valuation status and historical context — current P/B 0.61 (Low). For live price, earnings yield and the full fundamental profile, see ANG Lifesciences share price chart.
- Stock appears undervalued with PB of 0.61, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 36.5% below historical average
- Trading at premium to sector average PB of -0.93
ANG Lifesciences P/B Ratio Historical Trend
ANG annual price-to-book ratio — 4 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View ANG price range for the annual high/low range and current price position.
ANG Historical P/B Ratio — Book Value Per Share & Year-End Price
ANG Lifesciences annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.6 | ₹49.23 | ₹29.55 | ₹64 | Low |
| 2024 | 0.76 | ₹58.46 | ₹44.62 | ₹76 | Low |
| 2023 | 1.05 | ₹66.15 | ₹69.41 | ₹86 | Moderate |
| 2022 | 1.43 | ₹84.0 | ₹120.15 | ₹84 | Moderate |
ANG vs Healthcare Peers — P/B Ratio Comparison
ANG Lifesciences P/B 0.61 vs Healthcare average -0.93, median 0.6 — range -31.21–1.04.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |